News
Amakem raises €18m in a Series A round to advance its ...
test.pharmabiz.com
Jack Elands, CEO of Amakem, said: “Since Amakem's foundation in 2010, we have strongly advanced our Localized Drug Action platform and, in AMA0076, ... › news
Amakem raises €18 million for development of glaucoma ...
www.healio.com
— ... promising candidate for the treatment of one of the most important eye diseases," Jack Elands, CEO of Amakem, said in the release. › online
Amakem secures €1.4m grant - Manufacturing Chemist
www.manufacturingchemist.com
— Jack Elands, CEO of Amakem, said: 'This grant from the IWT again recognises the wide potential of our Localised Drug Action technology to ... › ...
Blink Biomedical: Announces Close of Series A Funding
www.einnews.com
— Jack Elands, Chief Executive Officer of BliNK Biomedical SAS, commented, "BliNK Biomedical welcomes the additional investment from Idinvest, ... › pr_news
sortiert nach Relevanz / Datum